Manejo de tumores perioculares mediante derivación a cirugía de Mohs y sus características clínico-histológicas

Abstract

Antecedents and Objectives

The aim of our study was to showcase that micrographic Mohs surgery (MMS) can be used efficiently even if unavailable (James Cook Hospital) in the management of periocular tumors through MMS via referral (Royal Victoria Infirmary Hospital), and describe our patients’ clinical and histological features.

Materials and methods

We conducted a retrospective, longitudinal and descriptive study with 58 patients. We categorized our patients in 3 groups; pre-COVID-19: patients from January 2019 through January 28^th 2020, COVID-19: patients from January 29^th 2020 through July 2021 and late COVID-19: patients from August 2021 through July 24^th 2023.

Results

No differences across groups were reported; the date of first consultation (DFC) and MMS (P = .06), the date of the referral request (DRR) and MMS (p = 0,054), the MMS date to reconstruction (P = .19), and the time of lesion onset (P = .054). The type of reconstruction was not impacted by the number of days between the clinic date and reconstruction (P = .60), the DFC and MMS (P = .60), and the DRR and MMS (P = .27). Nearly 16% of patients were discharged during their first postoperative visit.

Conclusion

The combined management of periocular tumors across 2 hospitals proved effective, even though the COVID-19 pandemic.